Valneva (VALN) News Today $10.64 -0.38 (-3.40%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VALN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Valneva stock falls after FDA suspension forces guidance cutOctober 7 at 12:26 PM | investing.comValneva Shares Slide After FDA Suspension Prompts Guidance RevisionOctober 7 at 12:26 PM | msn.comValneva (NASDAQ:VALN) Shares Gap Down - What's Next?October 7 at 11:53 AM | marketbeat.comValneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business UpdatesOctober 6 at 11:35 AM | globenewswire.comVALNEVA Declaration of shares and voting rights: September 30, 2025October 6 at 3:08 AM | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNOctober 3, 2025 | prnewswire.comLyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsightOctober 1, 2025 | finance.yahoo.comValneva’s Ixchiq shows 95% 4-year antibody persistence, shares up 10%September 30, 2025 | ca.investing.comValneva (NASDAQ:VALN) Sees Strong Trading Volume - Should You Buy?September 30, 2025 | marketbeat.comValneva Reports 95% Seroresponse Four Years After Single Shot of Chikungunya Vaccine IXCHIQ®September 30, 2025 | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedSeptember 29, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 28, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 24, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 23, 2025 | prnewswire.comVALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the FirmSeptember 18, 2025 | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?September 18, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 18, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 14, 2025 | globenewswire.comVaccine producer pledges to raise 10,000 for West Lothian charity partnerSeptember 13, 2025 | msn.comScotland’s largest vaccine producer pledges £10,000 to West Lothian charitySeptember 13, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 13, 2025 | prnewswire.comValneva SE Sponsored ADR (NASDAQ:VALN) Sees Significant Drop in Short InterestSeptember 13, 2025 | marketbeat.comValneva Scotland makes strides toward £10K fundraising goal in support of charity partner Team JakSeptember 12, 2025 | msn.comVALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the FirmSeptember 11, 2025 | globenewswire.comValneva (NASDAQ:VALN) Stock Price Up 5.6% - Should You Buy?September 11, 2025 | marketbeat.comLevi & Korsinsky Launches Fraud Investigation on Behalf of Valneva SE (VALN) ShareholdersSeptember 10, 2025 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 10, 2025 | globenewswire.comValneva (NASDAQ:VALN) Price Target Lowered to $13.00 at GuggenheimSeptember 10, 2025 | marketbeat.comA Lyme Disease Vaccine’s Final Test Results Could Appear By Yearend.September 9, 2025 | msn.comValneva price target lowered to $13 from $14 at GuggenheimSeptember 9, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNSeptember 8, 2025 | prnewswire.comShort Interest in Valneva SE Sponsored ADR (NASDAQ:VALN) Expands By 64.6%September 8, 2025 | marketbeat.comValneva (NASDAQ:VALN) Rating Increased to Hold at Wall Street ZenSeptember 8, 2025 | marketbeat.comValneva (NASDAQ:VALN) Trading Up 5% - Here's WhySeptember 5, 2025 | marketbeat.comVALNEVA Declaration of shares and voting rights: August 31, 2025September 5, 2025 | finance.yahoo.comVALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the FirmSeptember 4, 2025 | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Down - Here's What HappenedSeptember 4, 2025 | marketbeat.comValneva Reports Positive Phase 2 Results for Lyme Disease VaccineSeptember 3, 2025 | msn.comValneva Shares Rise on Lyme Disease Vaccine Study DataSeptember 3, 2025 | marketwatch.comValneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine CandidateSeptember 3, 2025 | globenewswire.comHC Wainwright Reiterates "Buy" Rating for Valneva (NASDAQ:VALN)August 27, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down - Time to Sell?August 27, 2025 | marketbeat.comValneva Outlook: Safety Blow To Ixchiq And Valuation ConcernsAugust 26, 2025 | seekingalpha.comValneva Stock Tumbles 19% After FDA Suspension Of Ixchiq License In US, Wall Street Divided On The ImpactAugust 26, 2025 | msn.comValneva stock tumbles as FDA suspends license for IXCHIQ vaccineAugust 25, 2025 | za.investing.comValneva Shares Tumble After Chikungunya Vaccine License Suspended in U.S.August 25, 2025 | marketwatch.comSafety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In USAugust 25, 2025 | benzinga.comValneva shares tumble after suspension of US chikungunya vaccine licenceAugust 25, 2025 | msn.comKeurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On MondayAugust 25, 2025 | benzinga.comJohnson Fistel Investigates Valneva Following FDA SuspensionAugust 25, 2025 | globenewswire.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.460.55▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼75▲VALN Articles Average Week Get the Latest News and Ratings for VALN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Valneva and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies INDV News NAMS News CNTA News AMRX News QURE News XENE News VKTX News CGON News MOR News IMVT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
